| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |